About Cellin Technologies

Take a look at the timeline and see how we grew from an idea into a cell therapy products contract manufacturing company.

2015 

Cellin Technologies begins technology transfer of MelCancerVac®. MelCancerVac® is a product by DanDrit Biotech USA, Inc. for colorectal cancer.

2013

Cellin Technologies receives an activity licence for the handling of cells and tissues from Estonian State Agency of Medicines.

2013

Cleanroom is closed for unauthorised persons. Only people with special training can enter the cleanroom.

2012

... sai tõeks. puhasruumi ehitamise algus. Puhasruum sai lähteplatvormiks rakuravi toodete valmistamiseks.

comes true. The beginning of cleanroom construction. This cleanroom will be our launchpad for the production of cell therapy products.

2008

Ettevõtte asukohaks sai Tallinna Teaduspark Tehnopol, mis asub Tallinna Tehnikaülikooli naabruses. The location of the company is chosen at Tallinn Science Park Tehnopol, near the Tallinn University of Technology.

2014

Cellin Tehcnologies receives the manufacturing authorisation for production of investigational cell therapy medicinal products.

August 15, 2013

The Big Day

Together with Biolaborid LLC, Cellin Technologies launches a state-of-the-art GMP cleanroom facility for the production of  high-quality cell therapy medicinal products.

2013

Our cleanroom is validated and is operating under the GMP requirements.

2010

Idee, mis momendil tundus uskumatuna ...An idea of something incredible ...

2008

Loodi biotehnoloogiaettevõte nimega Cellin Technologies, mis oli keskendunud teadus- ja arendustööle rakuravi rakenduste väljatöötamiseks. A biotech company focused on research and development of cell therapy applications is founded. It's called Cellin Technologies.

CELLIN TECHNOLOGIES
MÄEALUSE 4
TALLINN 12618
ESTONIA
E-mail: info@cellintechnologies.com
Phone: +372 502 2628
IBAN       EE552200221048073425
SWIFT    HABAEE2X 
VAT NR   EE101262352

©2021 by Cellin Technologies